Vanguard Fiduciary Trust
CRBP icon

Vanguard Fiduciary Trust’s Corbus Pharmaceuticals CRBP Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Buy
112,397
+16,156
+17% +$153K ﹤0.01% 3000
2026
Q1 		$904K Buy
+96,241
New +$810K ﹤0.01% 2967

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Fiduciary Trust's CRBP Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Corbus Pharmaceuticals (CRBP) stake by 17% in Q2 2026, buying an estimated $153K and bringing the position to 112,397 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

Vanguard Fiduciary Trust first reported a position in CRBP in Q1 2026 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Vanguard Fiduciary Trust held 112,397 shares of Corbus Pharmaceuticals worth $1.05M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 16,156 Corbus Pharmaceuticals shares in Q2 2026, an estimated $153K.
  • Corbus Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3000 holding.
  • Vanguard Fiduciary Trust first reported a position in Corbus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.